Back to Browse Journals » Clinical Interventions in Aging » Volume 2 » Issue 4

Testosterone replacement therapy for older men

Authors Stephen E Borst, Thomas Mulligan

Published 15 January 2008 Volume 2007:2(4) Pages 561—566


Stephen E Borst, Thomas Mulligan

Geriatrics Research, Education, and Clinical Center, North Florida/South Georgia Veterans Health System, Gainesville, FL, USA

Abstract: Despite intensive research on testosterone therapy for older men, important questions remain unanswered. The evidence clearly indicates that many older men display a partial androgen deficiency. In older men, low circulating testosterone is correlated with low muscle strength, with high adiposity, with insulin resistance and with poor cognitive performance. Testosterone replacement in older men has produced benefits, but not consistently so. The inconsistency may arise from differences in the dose and duration of testosterone treatment, as well as selection of the target population. Generally, studies reporting anabolic responses to testosterone have employed higher doses of testosterone for longer treatment periods and have targeted older men whose baseline circulating bioavailable testosterone levels were low. Most studies of testosterone replacement have reported anabolic that are modest compared to what can be achieved with resistance exercise training. However, several strategies currently under evaluation have the potential to produce greater anabolic effects and to do so in a safe manner. At this time, testosterone therapy can not be recommended for the general population of older men. Older men who are hypogonadal are at greater risk for the catabolic effects associated with a number of acute and chronic medical conditions. Future research is likely to reveal benefits of testosterone therapy for some of these special populations. Testosterone therapy produces a number of adverse effects, including worsening of sleep apnea, gynecomastia, polycythemia and elevation of PSA. Efficacy and adverse effects should be assessed frequently throughout the course of therapy.
Keywords: aging, testosterone, hypogonadism, physical function

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Functionalization of ethylene vinyl acetate with antimicrobial chlorhexidine hexametaphosphate nanoparticles

Wood NJ, Maddocks SE, Grady HJ, Collins AM, Barbour ME

International Journal of Nanomedicine 2014, 9:4145-4152

Published Date: 27 August 2014

Development of a liposome-based formulation for vitamin K1 nebulization on the skin

Campani V, Marchese D, Pitaro MT, Pitaro M, Grieco P, De Rosa G

International Journal of Nanomedicine 2014, 9:1823-1832

Published Date: 10 April 2014

Zerumbone-loaded nanostructured lipid carrier induces G2/M cell cycle arrest and apoptosis via mitochondrial pathway in a human lymphoblastic leukemia cell line

Rahman HS, Rasedee A, Abdul AB, Zeenathul NA, Othman HH, Yeap SK, How CW, Wan Nor Hafiza WAG

International Journal of Nanomedicine 2014, 9:527-538

Published Date: 16 January 2014

Effects of a hybrid micro/nanorod topography-modified titanium implant on adhesion and osteogenic differentiation in rat bone marrow mesenchymal stem cells

Zhang WJ, Li ZH, Huang QF, Xu L, Li JH, Jin YQ, Wang GF, Liu XY, Jiang XQ

International Journal of Nanomedicine 2013, 8:257-265

Published Date: 11 January 2013

Titanium dioxide induces apoptotic cell death through reactive oxygen species-mediated Fas upregulation and Bax activation

Yoo KC, Yoon CH, Kwon DW, Hyun KH, Woo SJ, Kim RK, Lim EJ, Suh YJ, Kim MJ, Yoon TH, Lee SJ

International Journal of Nanomedicine 2012, 7:1203-1214

Published Date: 5 March 2012

Use of calcium hydroxylapatite (Radiesse®) for facial augmentation

Patricio F Jacovella

Clinical Interventions in Aging 2008, 3:161-174

Published Date: 7 March 2008

Population-based health promotion perspective for older driver safety: Conceptual framework to intervention plan

Sherrilene Classen, Ellen DS Lopez, Sandra Winter, Kezia D Awadzi, Nita Ferree, et al

Clinical Interventions in Aging 2007, 2:677-693

Published Date: 15 January 2008